Potential barriers to insulin intensification in patients with Type 2 diabetes in the UK

被引：0
|
作者：
Feher, M. D. [1 ,2 ]
Vega-Hernandez, G. [3 ]
Ye, Q. E. [3 ]
Bogelund, M. [4 ]
机构：
[1] Chelsea & Westminster Hosp, Beta Cell Diabet Ctr, London, England
[2] Univ Warwick, Diabet Therapies Evaluat Network, Warwick, England
[3] Novo Nordisk Ltd, Gatwick, England
[4] Incentive, Holte, Denmark
来源：
DIABETIC MEDICINE | 2016年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P403
引用
收藏
页码：155 / 155
页数：1
相关论文
共 50 条
  • [21] Barriers to Insulin Progression Among Patients With Type 2 Diabetes A Systematic Review
    Polinski, Jennifer M.
    Smith, Benjamin F.
    Curtis, Bradley H.
    Seeger, John D.
    Choudhry, Niteesh K.
    Connolly, John G.
    Shrank, William H.
    DIABETES EDUCATOR, 2013, 39 (01): : 53 - 65
  • [22] Barriers to insulin initiation in elderly patients with type 2 diabetes mellitus in Brazil
    Eliaschewitz, Freddy G.
    de Paula, Mauricio A.
    Pedrosa, Hermelinda C.
    Pires, Antonio Carlos
    Salles, Joao Eduardo N.
    Tambascia, Marcos Antonio
    Turatti, Luiz Alberto A.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (01) : 39 - 44
  • [23] Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting
    Davies, Melanie J.
    Glah, Divina
    Chubb, Barrie
    Konidaris, Gerasimos
    McEwan, Phil
    PHARMACOECONOMICS, 2016, 34 (09) : 953 - 966
  • [24] Cost Effectiveness of IDegLira vs. Alternative Basal Insulin Intensification Therapies in Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in a UK Setting
    Melanie J. Davies
    Divina Glah
    Barrie Chubb
    Gerasimos Konidaris
    Phil McEwan
    PharmacoEconomics, 2016, 34 : 953 - 966
  • [25] Intensification of Human Insulin Therapy with SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus
    Dzida, Grzegorz J.
    Gajda, Piotr
    Masierek, Malgorzata
    DIABETES, 2024, 73
  • [26] Starting insulin in type 2 diabetes: Overcoming barriers to insulin therapy
    Kabadi, Udaya M.
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2008, 28 (02) : 65 - 68
  • [27] Effectiveness of Intensification Therapy in Patients with Type 2 Diabetes Who Used Basal Insulin Only
    Thomsen, Reimar W.
    Baggesen, Lisbeth M.
    Sogaard, Mette
    Pedersen, Lars
    Norrelund, Helene
    Buhl, Esben S.
    Haase, Christiane L.
    Johnsen, Soren P.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 9 - 10
  • [28] Effectiveness of intensification therapy in patients with type 2 diabetes who used basal insulin only
    Norrelund, H.
    Baggesen, L. M.
    Sogaard, M.
    Pedersen, L.
    Buhl, E. S.
    Haase, C. L.
    Johnsen, S. P.
    Thomsen, R. W.
    DIABETOLOGIA, 2015, 58 : S77 - S77
  • [29] Patterns and trends in insulin intensification among patients with type 2 diabetes in Western Pacific region
    Jabbar, A.
    Sheu, W. H-H
    Deerochanawong, C.
    Mirasol, R.
    Ozaki, R.
    WanMohamed, W. M. I.
    Qi, R.
    Treuer, T.
    DIABETOLOGIA, 2017, 60 : S311 - S311
  • [30] Impact of treatment intensification in patients with type 2 diabetes suboptimally controlled on basal insulin in The Health Improvement Network UK primary care database
    Lew, E.
    Myland, M.
    Nixon, M.
    Gooch, N.
    O'Leary, C.
    Shaunik, A.
    Jude, E. B.
    DIABETOLOGIA, 2018, 61 : S176 - S176
12345